Brief: Neubase Therapeutics Demonstrates Functional Rescue In Myotonic Dystrophy Type 1 Model And Allele-Selective Inhibition Of Kras Mutations To Inhibit Tumor Growth
08/06/2021 17:30
June 8 (Reuters) - NeuBase Therapeutics Inc NBSE.O :
* NEUBASE THERAPEUTICS DEMONSTRATES FUNCTIONAL RESCUE IN
MYOTONIC
DYSTROPHY TYPE 1 MODEL AND ALLELE-SELECTIVE INHIBITION OF KRAS
MUTATIONS TO INHIBIT TUMOR GROWTH
Source text for Eikon: ID:nGNX4JH24n
Further company coverage: NBSE.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on NeuBase Therapeutics
See all newsBrief: Neubase Therapeutics, On May 2, Was Notified By Nasdaq On Not Regained Compliance With Minimum Bid Price Requirement
Brief: Neubase Therapeutics Announces Receipt Of Notice From Nasdaq
U.S. STOCKS ON THE MOVE-TPG, R1 RCM, Zoom
U.S. STOCKS ON THE MOVE-Micron, Krystal Biotech, Pilgrim's Pride
U.S. STOCKS ON THE MOVE-Domino's Pizza, Voyager, Freshpet